SRS Capital Advisors »

Gain Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.8k 3.3k 1.77
2025-06-30 $4.5k 2.5k 1.80
2025-03-31 $4.8k 2.5k 1.91